VERICEL CORP (VCEL) Stock Price, Quote, News and Overview
NASDAQ:VCEL - Nasdaq - US92346J1088 - Common Stock - Currency: USD
VCEL Quote, Performance and Key Statistics
52
-2.31 (-4.25%)
The current stock price of VCEL is 52 USD. In the past month the price decreased by -9.44%. In the past year, price increased by 9.89%.
VCEL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About VCEL
Company Profile
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 314 full-time employees. The firm is a provider of advanced therapies for the sports medicine and severe burn care markets. The company markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The firm also holds a license for North American rights to NexoBrid (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for the removal of eschar in adults with deep partial-thickness and/or full-thickness burns.
Company Info
VERICEL CORP
64 Sidney St
Cambridge MASSACHUSETTS 02139 US
CEO: Dominick C. Colangelo
Employees: 314
Company Website: https://vcel.com/
Investor Relations: https://investors.vcel.com/
Phone: 17349305555
VERICEL CORP / VCEL FAQ
What is the stock price of VERICEL CORP today?
The current stock price of VCEL is 52 USD. The price decreased by -4.25% in the last trading session.
What is the ticker symbol for VERICEL CORP stock?
The exchange symbol of VERICEL CORP is VCEL and it is listed on the Nasdaq exchange.
On which exchange is VCEL stock listed?
VCEL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VERICEL CORP stock?
14 analysts have analysed VCEL and the average price target is 67.83 USD. This implies a price increase of 30.44% is expected in the next year compared to the current price of 52. Check the VERICEL CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VERICEL CORP worth?
VERICEL CORP (VCEL) has a market capitalization of 2.57B USD. This makes VCEL a Mid Cap stock.
How many employees does VERICEL CORP have?
VERICEL CORP (VCEL) currently has 314 employees.
What are the support and resistance levels for VERICEL CORP (VCEL) stock?
VERICEL CORP (VCEL) has a support level at 51.99 and a resistance level at 57.61. Check the full technical report for a detailed analysis of VCEL support and resistance levels.
Is VERICEL CORP (VCEL) expected to grow?
The Revenue of VERICEL CORP (VCEL) is expected to grow by 21.31% in the next year. Check the estimates tab for more information on the VCEL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VERICEL CORP (VCEL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VCEL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VCEL, evaluating the profitability, health, valuation and growth aspects
- VERICEL CORP (VCEL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VERICEL CORP (VCEL) Sales and EPS estimates to see what analysts future expectations are.
- VERICEL CORP (VCEL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VERICEL CORP (VCEL) Insider and Institutional Ownership to learn about the owners and their transactions.
- VERICEL CORP (VCEL) Stock Chart to make your own analysis
- VERICEL CORP (VCEL) Latest news and press-releases to stay up to date.
Does VERICEL CORP (VCEL) stock pay dividends?
VCEL does not pay a dividend.
When does VERICEL CORP (VCEL) report earnings?
VERICEL CORP (VCEL) will report earnings on 2025-02-27, before the market open.
What is the Price/Earnings (PE) ratio of VERICEL CORP (VCEL)?
The PE ratio for VERICEL CORP (VCEL) is 866.67. This is based on the reported non-GAAP earnings per share of 0.06 and the current share price of 52 USD. Check the full fundamental report for a full analysis of the valuation metrics for VCEL.
What is the Short Interest ratio of VERICEL CORP (VCEL) stock?
The outstanding short interest for VERICEL CORP (VCEL) is 7.69% of its float. Check the ownership tab for more information on the VCEL short interest.
VCEL Technical Analysis
VCEL Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to VCEL. VCEL has only an average score on both its financial health and profitability.
VCEL Financial Highlights
Over the last trailing twelve months VCEL reported a non-GAAP Earnings per Share(EPS) of 0.06. The EPS increased by 126.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.56% | ||
| ROA | 0.91% | ||
| ROE | 1.38% | ||
| Debt/Equity | 0 |
VCEL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 87% to VCEL. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 254.42% and a revenue growth 21.31% for VCEL